Frederick W Holly, Deceased

Title: Frederick W Holly: A Pioneer in Cyclic Octapeptide Research

Frederick W Holly, a notable inventor, made significant contributions to the field of neuropeptide research. He was based in Glenside, PA (US) and held one patent during his career. His work focused on the development of cyclic octapeptide analogs of neurotensin, which are crucial for understanding various physiological processes.

Latest Patents

Frederick W Holly's patent, titled "Cyclic Octapeptide Analogs of Neurotensin," showcases his innovative approach to neuropeptide analogs. This patent highlights the disclosed cyclic octapeptide analogs of the tridecapeptide neurotensin, which have potential applications in medical research and therapeutic development.

Career Highlights

Holly's career was marked by his association with Merck & Company, Inc., a leading pharmaceutical company. His work at Merck allowed him to explore the complexities of neuropeptides and their analogs, contributing to advancements in the field.

Collaborations

Throughout his career, Frederick W Holly collaborated with esteemed colleagues, including Marcia E Christy and Kenneth L Shepard. These collaborations fostered a productive environment for research and innovation.

Conclusion

Frederick W Holly's contributions to cyclic octapeptide research have left a lasting impact on the scientific community. His innovative work continues to inspire future research in neuropeptide analogs and their applications.